Discontinued — last reported Q4 '25
Johnson & Johnson D&A decreased by 8.5% to $1.78B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.7%, from $1.85B to $1.78B.
Higher values often reflect significant historical capital expenditures or acquisitions that are now being expensed over time.
A non-cash accounting expense that spreads the cost of tangible and intangible assets over their useful lives. This amou...
Capital-intensive tech companies with large data center footprints typically show high D&A relative to revenue.
cf_depreciation_and_amortization| Q2 '21 | Q2 '22 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.89B | $1.77B | $1.88B | $1.82B | $1.78B | $1.85B | $1.90B | $1.77B | $1.94B | $1.78B |
| QoQ Change | — | -6.6% | +6.3% | -3.5% | -1.8% | +3.6% | +2.7% | -6.5% | +9.7% | -8.5% |
| YoY Change | — | -6.6% | +6.3% | — | -5.2% | — | — | -2.4% | +9.0% | -3.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.